[Retracted] Sex Differences in the Relationship between Abdominal Obesity and Cardiovascular Death in Elderly Patients with Permanent Pacemakers Implantation: A Retrospective Cohort Study
Table 1
Baseline clinical characteristics.
Total
Men
Women
value
N
492
271
221
WC (cm; mean ± SD)
84.5 ± 12.7
87.4 ± 12.5
80.1 ± 11.8
<0.001
WC quartiles
0.03
1
131 (26.6)
60 (22.1)
71 (32.1)
2
174 (35.4)
98 (36.2)
76 (34.4)
3
187 (38.0)
113 (41.7)
74 (33.5)
BMI (kg/m2; mean ± SD)
23.5 ± 2.7
23.8 ± 2.6
23.3 ± 2.9
0.07
Age at implantation (year; mean ± SD)
71.9 ± 10.8
73.8 ± 10.3
69.7 ± 11.0
<0.01
NYHA class I-II (%)
461 (93.7)
252 (93.0)
209 (94.6)
0.48
Structure heart disease (%)
235 (47.8)
133 (49.1)
102 (46.2)
0.52
Hypertension (%)
253 (51.4)
139 (51.3)
114 (51.6)
0.95
Diabetes (%)
67 (13.6)
35 (12.9)
32 (14.5)
0.62
Atrial fibrillation (%)
70 (14.2)
40 (14.8)
30 (13.6)
0.71
Heart rate (bpm)
54.5 ± 10.5
55.7 ± 13.9
53.2 ± 15.2
0.01
Atrial pacing (%)
41.2 ± 36.2
39.2 ± 36.2
43.7 ± 36.1
0.17
Ventricular pacing (%)
59.7 ± 41.6
61.3 ± 40.3
57.7 ± 43.2
0.87
LVEF (%)
42.7 ± 14.9
59.2 ± 10.9
61.6 ± 9.8
<0.01
LAD (mm)
35.1 ± 7.0
35.2 ± 7.0
34.9 ± 7.0
0.58
LVEDD (mm)
48.9 ± 7.5
49.4 ± 5.7
48.2 ± 9.3
<0.01
Medications at discharge (%)
ACEI/ARB
126 (25.6)
70 (25.8)
56 (25.3)
0.90
Beta-blockers
143 (29.1)
84 (31.0)
59 (26.7)
0.26
Amiodarone
40 (8.1)
19 (7.0)
21 (9.5)
0.32
CCB
109 (22.2)
62 (22.9)
47 (21.3)
0.67
Digitalis
23 (4.7)
12 (4.4)
11 (5.0)
Statins
115 (23.4)
64 (23.6)
51 (23.1)
0.89
Aspirin
152 (30.9)
82 (30.3)
70 (31.7)
0.74
Abbreviations: ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; BMI = body mass index; LVEF = left ventricular ejection fraction; LAD = left atrial dimension; LVEDD = left ventricular end-systolic dimension; NYHA = New York heart association; CCB = calcium channel clockers; WC = waist circumference.
